# Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

> **NCT02607332** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT02607332
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607332, "Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02607332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*